Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SULFASALAZINE vs SUMATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SULFASALAZINE vs SUMATRIPTAN: Safety Overview

Metric SULFASALAZINE SUMATRIPTAN
Total FAERS Reports 40,160 17,442
Deaths Reported 4,179 305
Death Rate 10.4% 1.7%
Hospitalizations 10,284 1,580
Average Patient Age 48.6 yrs 45.7 yrs
% Female Patients 89.8% 84.9%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 14, 2014
Manufacturer Pfizer Laboratories Div Pfizer Inc Sun Pharmaceutical Industries, Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued